Our programs are direct-pay, with transparent pricing and no prior authorization required.
Philly pediatricians are using GLP-1 drugs to treat childhood obesity, but cost can be a major barrier, CHOP doctors find Out-of-pocket costs, insurance coverage, side effects and a lack of long-term safety data can be barriers to medication for childhood obesity
Additionally, even if its covered, patients may still be responsible for co-pays or out-of-pocket costs, depending on their insurances tiered pricing structure
Visible weight loss typically begins within 46 weeks
Fixed-effects models were applied under the assumption of a shared underlying effect size across datasets, while random-effects models accounted for potential heterogeneity among studies
The amount of weight you can lose with compounded Semaglutide GLP-1 varies from person to person